Ser204
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus®
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser204  -  GLI1 (human)

Site Information
GDMSsPNstGIQDPL   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 34426682

In vivo Characterization
Methods used to characterize site in vivo:
immunoprecipitation ( 1 ) , mass spectrometry ( 2 ) , mutation of modification site ( 1 ) , phospho-antibody ( 1 ) , western blotting ( 1 )
Disease tissue studied:
brain cancer ( 1 ) , medulloblastoma ( 1 )
Relevant cell line - cell type - tissue:
293T (epithelial) ( 1 ) , 3T3 (fibroblast) ( 1 ) , Daoy ( 1 ) , Jurkat (T lymphocyte) ( 2 )

Upstream Regulation
Putative in vivo kinases:
MEKK3 (human) ( 1 )

Downstream Regulation
Effects of modification on GLI1:
intracellular localization ( 1 ) , molecular association, regulation ( 1 )
Effects of modification on biological processes:
transcription, inhibited ( 1 )
Induce interaction with:
SUFU (human) ( 1 )
Inhibit interaction with:
DNA ( 1 )

References 

1

Lu J, et al. (2018) MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function. Oncogene
29662197   Curated Info

2

Mulhern D (2011) CST Curation Set: 12702; Year: 2011; Biosample/Treatment: cell line, Jurkat/calyculin_A & pervanadate; Disease: T cell leukemia; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: pSPX(I/L/M/V)
Curated Info